These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1914782)

  • 1. Lack of a pharmacokinetic interaction between doxapram and theophylline in apnea of prematurity.
    Jamali F; Coutts RT; Malek F; Finer NN; Peliowski A
    Dev Pharmacol Ther; 1991; 16(2):78-82. PubMed ID: 1914782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A comparative study about the therapeutic effect of theophylline and doxapram in apnoeic disorders].
    Möller JC; Austing A; Püst B; Kohl M; Reiss I; Iven H; Gortner L
    Klin Padiatr; 1999; 211(2):86-91. PubMed ID: 10407818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Doxapram dosage regimen in apnea of prematurity based on pharmacokinetic data.
    Jamali F; Barrington KJ; Finer NN; Coutts RT; Torok-Both GA
    Dev Pharmacol Ther; 1988; 11(5):253-7. PubMed ID: 3191816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response relationship of doxapram in the therapy for refractory idiopathic apnea of prematurity.
    Barrington KJ; Finer NN; Torok-Both G; Jamali F; Coutts RT
    Pediatrics; 1987 Jul; 80(1):22-7. PubMed ID: 3110729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of doxapram in idiopathic apnea of prematurity.
    Beaudry MA; Bradley JM; Gramlich LM; LeGatt D
    Dev Pharmacol Ther; 1988; 11(2):65-72. PubMed ID: 3371147
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of theophylline and caffeine after intravenous administration of aminophylline to premature neonates in Korea.
    Ahn HW; Shin WG; Park KJ; Suh OK; Choi JH
    Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):105-13. PubMed ID: 10850374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose doxapram for apnea unresponsive to aminophylline in very low birthweight infants.
    Brion LP; Vega-Rich C; Reinersman G; Roth P
    J Perinatol; 1991 Dec; 11(4):359-64. PubMed ID: 1770394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity.
    Peliowski A; Finer NN
    J Pediatr; 1990 Apr; 116(4):648-53. PubMed ID: 2181103
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (2):CD000075. PubMed ID: 10796115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxapram Treatment for Apnea of Prematurity: A Systematic Review.
    Vliegenthart RJ; Ten Hove CH; Onland W; van Kaam AH
    Neonatology; 2017; 111(2):162-171. PubMed ID: 27760427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal absorption of doxapram in neonates.
    Bairam A; Akramoff-Gershan L; Beharry K; Laudignon N; Papageorgiou A; Aranda JV
    Am J Perinatol; 1991 Mar; 8(2):110-3. PubMed ID: 2006935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose doxapram therapy in premature infants and its CSF and serum concentrations.
    Kumita H; Mizuno S; Shinohara M; Ichikawa T; Yamazaki T
    Acta Paediatr Scand; 1991; 80(8-9):786-91. PubMed ID: 1957596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of theophylline in neonates.
    Simons FE; Rigatto H; Simons KJ
    Semin Perinatol; 1981 Oct; 5(4):337-45. PubMed ID: 7302609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of theophylline in preterm neonates during the first month of life.
    Islam SI; Ali AS; Sheikh AA; Fida NM
    Saudi Med J; 2004 Apr; 25(4):459-65. PubMed ID: 15083216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aminophylline versus doxapram in idiopathic apnea of prematurity: a double-blind controlled study.
    Eyal F; Alpan G; Sagi E; Glick B; Peleg O; Dgani Y; Arad I
    Pediatrics; 1985 Apr; 75(4):709-13. PubMed ID: 3982903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy and reliability of dosing equations to individualize theophylline treatment of apnea of prematurity.
    Bhatt-Mehta V; Johnson CE; Donn SM; Spadoni V; Schork MA
    Pharmacotherapy; 1995; 15(2):246-50. PubMed ID: 7624272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isolated mental developmental delay in very low birth weight infants: association with prolonged doxapram therapy for apnea.
    Sreenan C; Etches PC; Demianczuk N; Robertson CM
    J Pediatr; 2001 Dec; 139(6):832-7. PubMed ID: 11743509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxapram versus methylxanthine for apnea in preterm infants.
    Henderson-Smart DJ; Steer P
    Cochrane Database Syst Rev; 2000; (4):CD000075. PubMed ID: 11034672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and physiological responses to prolonged nasogastric administration of doxapram for apnea of prematurity.
    Tay-Uyboco J; Kwiatkowski K; Cates DB; Seifert B; Hasan SU; Rigatto H
    Biol Neonate; 1991; 59(4):190-200. PubMed ID: 2070020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current options in the management of apnea of prematurity.
    Bhatia J
    Clin Pediatr (Phila); 2000 Jun; 39(6):327-36. PubMed ID: 10879934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.